Notes on Voltage- and Ligand-Gated Ion Channels

Overview of Ion Channels
  • Ion Channels as Drug Targets
    • Two types: Voltage-gated ion channels (VGICs) and Ligand-gated ion channels (LGICs)
    • Passage of ions determined by channel pore selectivity
    • Ion flux driven by the electrochemical gradient (influx/efflux)
Key Concepts in Ion Channels
  • Ion Channels Structure and Function
    • VGICs:
    • Present in excitable cells (e.g., muscle, nerve)
    • Types include Na+, K+, Ca2+, Cl-
    • Composed of a-subunit proteins with ancillary subunits
    • Function is gated by membrane potential and is crucial for action potentials
    • LGICs:
    • Receptors with conformational changes upon ligand binding
    • Examples include nicotinic ACh receptors and glutamate receptors
Voltage-Gated Ion Channels (VGICs)

  • Characteristics

    • Expressed in electrically excitable cells
    • Comprise one or more a-subunits, facilitating ion flow
    • Response to voltage changes generates action potentials
    • Key drug targets: anti-hypertensives and anti-seizure medications

  • Activation Mechanism

    • Closed at resting membrane potential (~-70 mV)
    • Rapidly open and close in response to depolarization
    • Cycle between resting (closed), active (open), and inactivated states
Examples of Voltage-Gated Ion Channel Drugs
  • Sodium Channels
    • Phenytoin: Anti-seizure, binds to inactive state, prolongs refractory period
    • Local anesthetics: Block nerve conduction
  • Calcium Channels
    • Gabapentin & Pregabalin: Bind to ancillary subunit, block neurotransmitter release
  • Potassium Channels
    • Retigabine: Activates Kv7 channels, regulates neuronal excitability
Ligand-Gated Ion Channels (LGICs)

  • Characteristics

    • Known as ionotropic receptors, significant for fast synaptic transmission
    • Activated by ligand binding to orthosteric sites, with possible modulation by allosteric sites

  • Structural Composition

    • Composed of multiple independent protein subunits
    • Present in various patterns, contributing to their pharmacological properties
Examples of Ligand-Gated Ion Channel Drugs

  • Nicotinic ACh Receptors

    • Agonists: Acetylcholine, Nicotine, Varenicline
    • Antagonists: Tubocurarine, Pancuronium, Suxamethonium
    • Non-selective cation channel behavior: Permeable to Na+ and K+

  • GABAA Receptors

    • Agonists: Ethanol, Benzodiazepines, General anesthetics
    • Main action: Chloride influx for hyperpolarization and inhibition

  • Glutamate Receptors

    • Types include AMPA, Kainate, NMDA
    • Non-competitive antagonists: Phencyclidine, Ketamine, Memantine
Conclusion
  • VGICs and LGICs are critical drug targets with diverse physiological roles
  • VGICs operate mainly in excitable cells, while LGICs include a broader range of cell types
  • The diversity in subunit assembly allows for targeted drug design and therapeutic applications.